An observational nationwide register based cohort study on lamotrigine versus lithium in bipolar disorder

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

An observational nationwide register based cohort study on lamotrigine versus lithium in bipolar disorder. / Kessing, Lars Vedel; Hellmund, Gunnar; Andersen, Per Kragh.

In: Journal of Psychopharmacology, Vol. 26, 2012, p. 644-652.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Kessing, LV, Hellmund, G & Andersen, PK 2012, 'An observational nationwide register based cohort study on lamotrigine versus lithium in bipolar disorder', Journal of Psychopharmacology, vol. 26, pp. 644-652. https://doi.org/10.1177/0269881111414091

APA

Kessing, L. V., Hellmund, G., & Andersen, P. K. (2012). An observational nationwide register based cohort study on lamotrigine versus lithium in bipolar disorder. Journal of Psychopharmacology, 26, 644-652. https://doi.org/10.1177/0269881111414091

Vancouver

Kessing LV, Hellmund G, Andersen PK. An observational nationwide register based cohort study on lamotrigine versus lithium in bipolar disorder. Journal of Psychopharmacology. 2012;26:644-652. https://doi.org/10.1177/0269881111414091

Author

Kessing, Lars Vedel ; Hellmund, Gunnar ; Andersen, Per Kragh. / An observational nationwide register based cohort study on lamotrigine versus lithium in bipolar disorder. In: Journal of Psychopharmacology. 2012 ; Vol. 26. pp. 644-652.

Bibtex

@article{ba0afb5afc4e4fcc9138d01c95d425b9,
title = "An observational nationwide register based cohort study on lamotrigine versus lithium in bipolar disorder",
abstract = "It is not clear whether the effectiveness of lamotrigine versus lithium differs for patients with bipolar disorder treated in clinical practice. We compared rates of switch to, or add on of, another psychotropic, and rates of psychiatric hospitalization for patients treated with lamotrigine or lithium in clinical practice. Using linkage of nationwide Danish registers we identified 730 patients who received lamotrigine and 3518 patients received lithium subsequent to a diagnosis of bipolar disorder in psychiatric hospital settings during a period from 1995 to 2006. The overall rate of switch to or add on of another psychotropic (the opposite drug of interest (lithium or lamotrigine), antidepressants, antipsychotics or other anticonvulsants than lamotrigine) was increased for lamotrigine compared with lithium (HR = 2.60, 95{\%} CI: 2.23-3.04), regardless of whether the index episode was depressive, manic, mixed or remission. In addition, the overall rate of psychiatric hospitalization was increased for lamotrigine compared with lithium (HR = 1.45, 95{\%} CI: 1.28-1.65), as were the rates for patients with a depressive (HR = 1.31, 95{\%} CI: 1.01-1.70) and patients with a manic (HR = 1.65, 95{\%} CI: 1.31-2.09) index episode. Rates did not differ significantly between the drugs for patients with a mixed index episode and for patients in remission. It is concluded that in daily clinical practice, treatment with lithium is in general superior to treatment with lamotrigine.",
author = "Kessing, {Lars Vedel} and Gunnar Hellmund and Andersen, {Per Kragh}",
year = "2012",
doi = "http://dx.doi.org/10.1177/0269881111414091",
language = "English",
volume = "26",
pages = "644--652",
journal = "Journal of Psychopharmacology",
issn = "0269-8811",
publisher = "SAGE Publications",

}

RIS

TY - JOUR

T1 - An observational nationwide register based cohort study on lamotrigine versus lithium in bipolar disorder

AU - Kessing, Lars Vedel

AU - Hellmund, Gunnar

AU - Andersen, Per Kragh

PY - 2012

Y1 - 2012

N2 - It is not clear whether the effectiveness of lamotrigine versus lithium differs for patients with bipolar disorder treated in clinical practice. We compared rates of switch to, or add on of, another psychotropic, and rates of psychiatric hospitalization for patients treated with lamotrigine or lithium in clinical practice. Using linkage of nationwide Danish registers we identified 730 patients who received lamotrigine and 3518 patients received lithium subsequent to a diagnosis of bipolar disorder in psychiatric hospital settings during a period from 1995 to 2006. The overall rate of switch to or add on of another psychotropic (the opposite drug of interest (lithium or lamotrigine), antidepressants, antipsychotics or other anticonvulsants than lamotrigine) was increased for lamotrigine compared with lithium (HR = 2.60, 95% CI: 2.23-3.04), regardless of whether the index episode was depressive, manic, mixed or remission. In addition, the overall rate of psychiatric hospitalization was increased for lamotrigine compared with lithium (HR = 1.45, 95% CI: 1.28-1.65), as were the rates for patients with a depressive (HR = 1.31, 95% CI: 1.01-1.70) and patients with a manic (HR = 1.65, 95% CI: 1.31-2.09) index episode. Rates did not differ significantly between the drugs for patients with a mixed index episode and for patients in remission. It is concluded that in daily clinical practice, treatment with lithium is in general superior to treatment with lamotrigine.

AB - It is not clear whether the effectiveness of lamotrigine versus lithium differs for patients with bipolar disorder treated in clinical practice. We compared rates of switch to, or add on of, another psychotropic, and rates of psychiatric hospitalization for patients treated with lamotrigine or lithium in clinical practice. Using linkage of nationwide Danish registers we identified 730 patients who received lamotrigine and 3518 patients received lithium subsequent to a diagnosis of bipolar disorder in psychiatric hospital settings during a period from 1995 to 2006. The overall rate of switch to or add on of another psychotropic (the opposite drug of interest (lithium or lamotrigine), antidepressants, antipsychotics or other anticonvulsants than lamotrigine) was increased for lamotrigine compared with lithium (HR = 2.60, 95% CI: 2.23-3.04), regardless of whether the index episode was depressive, manic, mixed or remission. In addition, the overall rate of psychiatric hospitalization was increased for lamotrigine compared with lithium (HR = 1.45, 95% CI: 1.28-1.65), as were the rates for patients with a depressive (HR = 1.31, 95% CI: 1.01-1.70) and patients with a manic (HR = 1.65, 95% CI: 1.31-2.09) index episode. Rates did not differ significantly between the drugs for patients with a mixed index episode and for patients in remission. It is concluded that in daily clinical practice, treatment with lithium is in general superior to treatment with lamotrigine.

U2 - http://dx.doi.org/10.1177/0269881111414091

DO - http://dx.doi.org/10.1177/0269881111414091

M3 - Journal article

VL - 26

SP - 644

EP - 652

JO - Journal of Psychopharmacology

JF - Journal of Psychopharmacology

SN - 0269-8811

ER -

ID: 40169784